''We have received several additional reports of individuals in the 15-18 year age group being administered unapproved COVID-19 vaccines,'' the company said.
Covaxin's booster dose is able to neutralise the vaccine evading Omicron variant of Covid-19, according to a study conducted at US' Emory University, Bharat Biotech announced on Wednesday.
Bharat Biotech says its trial of Covaxin booster jabs has demonstrated long-term safety with no serious adverse events .
Earlier, the Hyderabad-based manufacturer has proposed the booster dose for those who have been already been innoculated against COVID with Covishield and Covaxin vaccines.
Bharat Biotech on Wednesday said no painkillers or paracetamol are recommended after being vaccinated with its COVID-19 vaccine Covaxin.
This is false and misleading and based on incomplete information, the health ministry said in a statement.
The data was submitted to the Central Drugs Standard Control Organisation (CDSCO) in October 2021 and received emergency use nod for children aged 12-18 from DCGI recently
Hyderabad based vaccine manufacturer Bharat Biotech on Thursday announced that BBV152 (Covaxin), its whole-virion inactivated COVID-19 vaccine candidate, has proven to be safe, well-tolerated, and...
Union Health Minister Mansukh Mandaviya on Tuesday said that the Central Drug Authority CDSCO has approved the Serum Institute of India's COVID-19 vaccine Covovax, Biological E's jab Corbevax and...
So far six COVID-19 vaccines Serum Institute's Covishield, Bharat Biotech's Covaxin, Zydus Cadila's ZyCoV-D, Russia's Sputnik V and the US-made Moderna and Johnson and Johnson have received emergency...